Coloplast A/S (CLPBY) Earnings Date, Estimates & Call Transcripts $9.58 -0.02 (-0.22%) As of 03:58 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Coloplast A/S Earnings Summary Coloplast A/S posted Q3 2025 earnings on August 19, 2025, reporting an EPS of $0.06, which missed the consensus estimate of $0.09 by $0.03. Quarterly revenue was reported to be $1.09 billion, below the consensus estimate of $7.10 billion. With a trailing EPS of $0.27 and a P/E Ratio of 35.48, Coloplast A/S's earnings are expected to grow 29.03% next year, from $0.31 to $0.40 per share. Q3 2025 Earnings ResourcesQ3 2025 Earnings ReportCLPBY Upcoming EarningsColoplast A/S's next earnings date is estimated for Tuesday, November 4, 2025, based on past reporting schedules. Upcoming Q4 Earnings DateNov. 4Before Market OpensEstimatedConsensus EPS (Aug. 19) $0.09 Actual EPS (Aug. 19) $0.06 Missed By -$0.03 Actual Revenue (Aug. 19) $1.09B Get Coloplast A/S Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataCLPBY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLPBY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Coloplast A/S Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $0.31 EPSNext Year EPS Consensus Estimate $0.40 EPS Coloplast A/S Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/4/2025(Estimated)--------8/19/2025Q3 2025$0.0920$0.06 -$0.0320$0.05$7.10B$1.09B5/6/2025Q2 2025$0.0874$0.06 -$0.0274$0.06$7.02B$1.05B2/4/2025Q1 2025$0.08$0.07 -$0.01$0.07--11/5/2024Q4 2024-$0.08-$0.07-$1.02B8/20/2024Q3 2024-$0.08-$0.08-$993.49M5/7/2024Q2 2024$0.08$0.08-$0.08-$959.05M2/9/2024Q4 2023$0.08$0.08-$0.08-$953.60M11/9/2023Q4 2023-$0.08-$0.08-$909.23M Coloplast A/S Earnings - Frequently Asked Questions When is Coloplast A/S's earnings date? Coloplast A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 4th, 2025 based off last year's report dates. Learn more on CLPBY's earnings history. What guidance has Coloplast A/S issued on next quarter's earnings? Coloplast A/S issued an update on its FY 2025 earnings guidance on Tuesday, August, 19th. The company issued revenue guidance of $4.2 billion-$4.4 billion, compared to the consensus revenue estimate of $4.4 billion. Did Coloplast A/S beat their earnings estimates last quarter? In the previous quarter, Coloplast A/S (OTCMKTS:CLPBY) missed the analysts' consensus estimate of $0.09 by $0.03 with a reported earnings per share (EPS) of $0.06. Learn more on analysts' earnings estimate vs. CLPBY's actual earnings. How much revenue does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded annual revenue of $3.93 billion. How much profit does Coloplast A/S generate each year? Coloplast A/S (OTCMKTS:CLPBY) has a recorded net income of $734.56 million. CLPBY has generated $0.27 earnings per share over the last four quarters. What is Coloplast A/S's price-to-earnings ratio? Coloplast A/S (OTCMKTS:CLPBY) has a trailing price-to-earnings ratio of 35.41 and a forward price-to-earnings ratio of 30.85. The price/earnings-to-growth ratio is 3.68. What is Coloplast A/S's EPS forecast for next year? Coloplast A/S's earnings are expected to grow from $0.31 per share to $0.40 per share in the next year, which is a 29.03% increase. More Earnings Resources from MarketBeat Related Companies FMS Earnings Results PBIO Earnings Results SARTF Earnings Results TMO Earnings Results ISRG Earnings Results IDXX Earnings Results EW Earnings Results ALC Earnings Results IQV Earnings Results DXCM Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (OTCMKTS:CLPBY) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access